Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Pricing snapshots
Regulatory databases
Product category trackers
Regulatory reports
Market reports
Infographics
Market Snapshots
News analysis
Flavour & nicotine trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Louisiana - United States Bill aims to ban all flavours bar tobacco…
  • Brazil Banned or legal? Status of e-cigs to be settled ‘this year’…
  • Germany Untaxed e-liquids seized after retailers’ transitional period ends…
  • Egypt Health ministry warns strongly against e-cigarettes…
  • Netherlands Figures show sharp rise in vaping by young people…
  • United States Juul and Altria face trial over alleged marketing of e-cigs to kids…
  • Switzerland Study reveals level of e-cig use by 15-year-olds…
  • Egypt Ramadan suggested as good opportunity to quit tobacco…
  • Egypt Senate passes bill that could place further restrictions on e-cigs…
  • Philippines BIR and FDA issue clarifications and reminders about regulations…
  • New Zealand Vaping Regulatory Authority reviewing company responses on compliance…
  • Lithuania THC to be banned in tobacco products including e-cigs as of 1st April…
View all
Resources

SEC (Sociedad Española de Cardiología) (Spanish Society of Cardiology)

Written by || 30th April 2014 || Resources || Health and science | Market Research | Policy and Politics | Europe Spain

The SEC does not recommend e-cigarettes as a valid way to quit conventional tobacco and would like to see emergency regulation and control implemented. www.secardiologia.es/ Calle de Nuestra Señora de Guadalupe, Nº 5 y 7
Madrid
28028, España)
Teléfono: 91 724 23 70
Fax: 91 724 23 71 Contact via online form ...

Restricted content. Do you want to read more?

Read our latest free content

Our disposable environment – from one discarded vape to a world of regulation
Meta removes Australian lobby group’s Facebook ads encouraging vape sales
US FDA rewrites the rule book at length – but does it really change anything?
Tamarind Intelligence – analysis and data trusted by governments and beyond
Altria commits to $2.75bn Njoy purchase, banking on FDA-approved US vape sales
TPD, advertising limits and tax – Europe’s ‘three levers’ against tobacco and e-cigs